- Details
- Description
Packaging Size:
1bottle/Box
Strength:
125mg(10mL)
Composition:
Cadonilimab
Treatment:
Relapsed or metastatic cervical cancer
Form:
Injection
Brand:
开坦尼
Quantity Unit:
125mg(10mL)/Bottle/Box
Manufacturer:
Akeso, Inc.,China
Cadonilimab is a bispecific antibody that targets the PD-1 and CTLA-4 receptors on tumor cells to treat various solid cancers. In June 2022, cadonilimab was approved in China for use in patients with relapsed or metastatic cervical cancer.
- Cadonilimab sold under the brand name 开坦尼® in china.
